Journal Article

Does a humoral correlate of protection exist for SARS-CoV-2? A systematic review

Bolotin, Shelly, Perry, Julie, Wright, James, Osman, Selma, Buchan, Sarah A., Sadarangani, Manish, Richard-Greenblatt, Melissa

2022

Overview

A correlate of protection (CoP) is an immunological marker associated with protection against infection. Despite an urgent need, a CoP for SARS-CoV-2 is currently undefined. Our objective was to review the evidence for a humoral correlate of protection for SARS-CoV-2, including variants of concern. We searched OVID MEDLINE, EMBASE, Global Health, Biosis Previews and Scopus to January 4, 2022 and pre-prints (using NIH iSearch COVID-19 portfolio) to December 31, 2021, for studies describing SARS-CoV-2 re-infection or breakthrough infection with associated antibody measures. Two reviewers independently extracted study data and performed quality assessment. Twenty-five studies were included in our systematic review. Two studies examined the correlation of antibody levels to VE, and reported values from 48.5% to 94.2%. Similarly, several studies found an inverse relationship between antibody levels and infection incidence, risk, or viral load, suggesting that both humoral immunity and other immune components contribute to protection. However, individual level data suggest infection can still occur in the presence of high levels of antibodies. Two studies estimated a quantitative CoP: for Ancestral SARS-CoV-2, these included 154 (95% confidence interval (CI) 42, 559) anti-S binding antibody units/mL (BAU/mL), and 28.6% (95% CI 19.2, 29.2%) of the mean convalescent antibody level following infection. One study reported a CoP for the Alpha (B.1.1.7) variant of concern of 171 (95% CI 57, 519) BAU/mL. No studies have yet reported an Omicron-specific CoP. Our review suggests that a SARS-CoV-2 CoP is likely relative, where higher antibody levels decrease the risk of infection, but do not eliminate it completely. More work is urgently needed in this area to establish a SARS-CoV-2 CoP and guide policy as the pandemic continues.

• Publisher: Public Library of Science,Public Library of Science (PLoS)
• Subject: Antibodies / Antibodies, Viral / Biology and Life Sciences / Canada / Confidence intervals / COVID-19 / Disease / Epidemics / Forecasts and trends / Global health / Health aspects / Health risks / Humans / Humoral immunity / Immunology / Infections / Laboratories / Medicine and Health Sciences / Pandemics / Public health / Quality assessment / Quality control / Research and Analysis Methods / Reviews / Risk reduction / SARS-CoV-2 / Serology / Severe acute respiratory syndrome / Severe acute respiratory syndrome coronavirus 2 / Systematic review / Vaccines / Viral antibodies / Viral diseases